Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy
about
Clinical significance of androgen secretion disorders in men with a malignancy.Metabolic changes in patients with prostate cancer during androgen deprivation therapy.The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience.
P2860
Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolic syndrome in patients ...... t androgen-deprivation therapy
@en
type
label
Metabolic syndrome in patients ...... t androgen-deprivation therapy
@en
prefLabel
Metabolic syndrome in patients ...... t androgen-deprivation therapy
@en
P2093
P2860
P356
P1476
Metabolic syndrome in patients ...... t androgen-deprivation therapy
@en
P2093
Behzad Feyzzadeh Kerigh
Mohammadali Mohammadzadeh Rezaei
Mohammadhadi Mohammadzadeh Rezaei
P2860
P304
P356
10.5489/CUAJ.3655
P577
2016-09-13T00:00:00Z